Trials / Recruiting
RecruitingNCT06590623
The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- University of British Columbia · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
To conduct a single-arm pilot study to determine how acute ingestion of an exogenous ketone monoester supplement alters the histone lysine β-hydroxybutyrylation and immune function in healthy human monocytes and lymphocytes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ketone Monoester (KE) | Participants will receive an exogenous ketone supplement (KetoneAid KE4) in a fasted state in the morning, at a dosage of 0.75 g/kg of body weight. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-06-01
- Completion
- 2025-06-01
- First posted
- 2024-09-19
- Last updated
- 2025-03-07
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06590623. Inclusion in this directory is not an endorsement.